Additional file 2: of A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method (2019)

First Author: North B

Attributed to: MICA: Early phase clinical trial repurposing ATRA as stromal targeting agent in a novel drug combination for pancreatic cancer (STAR-PAC) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.6084/m9.figshare.8330966

Publication URI: https://springernature.figshare.com/articles/Additional_file_2_of_A_new_pragmatic_design_for_dose_escalation_in_phase_1_clinical_trials_using_an_adaptive_continual_reassessment_method/8330966

Type: Other